NPM1-mutated acute myeloid leukemia: from bench to bedside.
Falini B, Brunetti L, Sportoletti P, Martelli MP.
Blood. 2020 Oct 8;136(15):1707-1721. doi: 10.1182/blood.2019004226.
Recent advances in AML with mutated NPM1.
Ishikawa Y, Ushijima Y, Kiyoi H.
Int J Hematol. 2024 Nov;120(5):556-565. doi: 10.1007/s12185-024-03835-8. Epub 2024 Aug 22.
Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, Potter NE, Heuser M, Thol F, Bolli N, Gundem G, Van Loo P, Martincorena I, Ganly P, Mudie L, McLaren S, O'Meara S, Raine K, Jones DR, Teague JW, Butler AP, Greaves MF, Ganser A, Döhner K, Schlenk RF, Döhner H, Campbell PJ.
N Engl J Med. 2016 Jun 9;374(23):2209-2221. doi: 10.1056/NEJMoa1516192.
Clinical outcomes associated with NPM1 mutations in patients with relapsed or refractory AML.
Issa GC, Bidikian A, Venugopal S, Konopleva M, DiNardo CD, Kadia TM, Borthakur G, Jabbour E, Pemmaraju N, Yilmaz M, Short NJ, Maiti A, Sasaki K, Masarova L, Pierce S, Takahashi K, Tang G, Loghavi S, Patel K, Andreeff M, Bhalla K, Garcia-Manero G, Ravandi F, Kantarjian H, Daver N.
Blood Adv. 2023 Mar 28;7(6):933-942. doi: 10.1182/bloodadvances.2022008316.
Significance of NPM1 Gene Mutations in AML.
Hindley A, Catherwood MA, McMullin MF, Mills KI.
Int J Mol Sci. 2021 Sep 17;22(18):10040. doi: 10.3390/ijms221810040.
NPM1-Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions.
Patel SS.
Pathobiology. 2024;91(1):18-29. doi: 10.1159/000530253. Epub 2023 Mar 21.
NPM1-mutated AML: how many diseases?
Itzykson R.
Blood. 2024 Aug 15;144(7):681-683. doi: 10.1182/blood.2024025032.
NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse.
Höllein A, Meggendorfer M, Dicker F, Jeromin S, Nadarajah N, Kern W, Haferlach C, Haferlach T.
Blood Adv. 2018 Nov 27;2(22):3118-3125. doi: 10.1182/bloodadvances.2018023432.
NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
Forghieri F, Nasillo V, Paolini A, Bettelli F, Pioli V, Giusti D, Gilioli A, Colasante C, Acquaviva G, Riva G, Barozzi P, Maffei R, Potenza L, Marasca R, Fozza C, Tagliafico E, Trenti T, Comoli P, Longo G, Luppi M.
Int J Mol Sci. 2020 Nov 26;21(23):8975. doi: 10.3390/ijms21238975.
Common Driver Mutations in AML: Biological Impact, Clinical Considerations, and Treatment Strategies.
Nong T, Mehra S, Taylor J.
Cells. 2024 Aug 21;13(16):1392. doi: 10.3390/cells13161392.
